USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS

USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS

Course:
NBME PHARMACOLOGY

Institution:
NBME PHARMACOLOGY

USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS

Preview (2 out of 8 pages)

USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS

After purchase, you get:

✅ Instant PDF Download
✅ Verified answer explanations
✅ Refund if not Satisfied
✅ Prepared for 2025/2026 test cycle

Document Information
Uploaded on: September 8, 2025
Last updated: September 8, 2025
Number of pages:8
Written in:2025/2026
Type:Exam (elaborations)
Contains:Questions & Answers
Tags:USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS
Seller Information
Profile

SophiaBennett

Reviews Received
★★★★★
1
20
★★★★
1
8
★★★
1
5
★★
1
9
1
3
User Reviews (0)

Content Preview

USMLE STEP 3 - DRUG MOA (INDICATIONS) EXAM 2025 QUESTIONS AND ANSWERS Erythromycin - ....ANSWER ...-50S ribosome, inhibits TRANSLOCATION (movement of tRNA-aa from acceptor site to peptidyl site) clindamycin, chloramphenicol - ....ANSWER ...-50 ribosome, inhibits PEPTIDYL TRANSFERASE (incorporation of new a.a.'s into growing strand) linezolid - ....ANSWER ...-50S protein synthesis inhibitor tetracycline - ....ANSWER ...-30S ribosome, blocks tRNA-aa from binding to ACCEPTOR SITE on mRNA aminoglycosides - ....ANSWER ...-30S ribosome, blocks INITIATION of translation and induces PREMATURE TERMINATION or mistranslation vancomycin - ....ANSWER ...-binds D-ala-D-ala portion of cell wall precursors, prevents POLYMERIZATION OF PEPTIDOGLYCANS ....COPYRIGHT ©️ 2025 ALL RIGHTS RESERVED...TRUSTED & VERIFIED 1